At the recent Asian Pacific Digestive Week (APDW) 2016 held in Kobe, Japan, three prominent international experts shared their views on gastroesophageal reflux disease (GERD) and the challenges of its management.
Recently, randomized controlled trials and guidelines have brought to light the benefits of extending the duration of H. pylori treatment. Below are summaries of guidelines and trials examining the regimens used to manage the infection.
At the recent Annual Scientific Congress of the Malaysian Society of Gastroenterology and Hepatology (GUT 2016), held at Shangri-La Hotel, Kuala Lumpur, an expert from Hong Kong spoke on the role of direct-acting antivirals as well as pan-genotypic agents that are set to revolutionize hepatitis C treatment.
Sorafenib appears to be well-tolerated in patients with hepatocellular carcinoma (HCC), with the subgroup of Child-Pugh B patients having a shorter treatment duration and higher serious adverse event (SAE) incidence, according to the results of a subgroup analysis of GIDEON*.
An expert panel meeting on hepatorenal syndrome (HRS) was recently convened in Kuala Lumpur with the aim of discussing management practices in different hospital settings. Chaired by Professor Sanjiv Mahadeva, consultant gastroenterologist, University Malaya Medical Centre, the meeting saw local and regional experts share HRS cases they have encountered in their practice.
As its name suggests, inflammatory bowel disease (IBD), which encompasses ulcerative colitis and Crohn’s disease, involves chronic inflammation of the digestive tract. IBD is a common disease in the West, afflicting more than 5 million people.2 Although IBD is still rare in Southeast Asia, the incidence appears to be on the rise in Malaysia, with a rate of 0.67 per 100,000 population.3 It is noteworthy that early detection and management of IBD can reduce a significant amount of pain and stress for patients. Thus, general practitioners (GPs), who are experts trained to work in the front line of a healthcare system, play a vital role in reducing the burden of IBD through immediate referral of suspected IBD patients for specialist investigations.
The term probiotic is coined from a peculiar combination of a Latin word pro (meaning in favour of) and a Greek word bios (meaning life) with the intention to convey the idea of being opposite to antibiotic. Following many refinements to its definition, probiotics today refer to live microorganisms taken for health benefits and have in more recent times seen increasing use for various purposes. At a recent symposium, Professor Keya Rani Lahiri discussed the safety and efficacy of the probiotic Bacillus clausii (Enterogermina®, sanofi-aventis) in paediatric diarrhoea.
The Malaysian Paediatric Association's 37th Annual Congress and the Asia Pacific Vaccinology Update saw two eminent speakers discussing the rationale for vaccination against rotavirus and Streptococcus pneumoniae infections in children.
One in 7 patients diagnosed with colorectal cancer (CRC) are below the recommended average-risk screening age of 50, according to a population-based cohort study, which suggests the need for CRC screening policy changes.
A once-daily oral dose of the direct-acting antiviral agents (DAAs) ledipasvir/sofosbuvir (LDV/SOF) is safe and effective in treating adolescent genotype 1 (GT1) hepatitis C (HCV) patients, according to results of astudy presented at the annual meeting of the European Association for the Study of the Liver (EASL) International Liver Congress™ (ILC) 2016 in Barcelona, Spain.